We have located links that may give you full text access.
Journal Article
Review
Phacoanaphylactic endophthalmitis.
Survey of Ophthalmology 1992 March
Phacoanaphylactic endophthalmitis is a rare disease that develops infrequently after lens injury. The recent popularity of extracapsular cataract extraction with intraocular lens implants and the recently described possible association of low-grade infections have stimulated renewed interest in phacoanaphylactic endophthalmitis. It was formerly believed that this disease was due to the rejection of a lens protein that had been sequestered prior to lens injury. Recent observations indicate that this concept is incorrect and that phacoanaphylactic endophthalmitis represents altered tolerance to lens proteins. Clinical and histopathologic features as well as controversies in clinical management are discussed. Recent evidence concerning mechanisms of pathogenesis is reviewed [corrected].
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app